These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 330747)

  • 21. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo effects of rabbit anti-mouse brain serum on theta bearing lymphocytes of AKR mice.
    Filppi JA; Rheins MS; Pierre RL
    Immunology; 1975 Apr; 28(4):659-68. PubMed ID: 1097331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G; Collavo D; Chieco-Bianchi L
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D; Flyer DC
    J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
    Yutoku M; Grossberg AL; Pressman D
    J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Humoral reactions in BALC/c mice with sarcomatous Moloney-induced tumor].
    Yakimenko LV; Vetrova EP; Kaminskaya LP; Berdova AG; Umansky YA
    Vopr Onkol; 1979; 25(9):46-50. PubMed ID: 573520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive activity of antibody directed against endogenous C-type virus interferes with early events of the immune response.
    Schumann G; Moroni C
    J Immunol; 1978 Jun; 120(6):1913-6. PubMed ID: 207777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage-induced reversal of immunosuppression by leukemia viruses.
    Specter SC; Bendinelli M; Ceglowski WS; Friedman H
    Fed Proc; 1978 Jan; 37(1):97-101. PubMed ID: 201505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
    Fernandez-Cruz E; Halliburton B; Feldman JD
    J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.